NCT06830096View on ClinicalTrials.gov

Role of KATP Channel Loss in Type 2 Diabetes

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 7, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

July 1, 2026

Conditions
Obesity and Type 2 Diabetes
Interventions
DRUG

10 mg glipizide ingestion

A single dose of 10 mg glipizide will be ingested

Trial Locations (1)

63110

RECRUITING

Washington University in St. Louis, St Louis

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Washington University School of Medicine

OTHER